1The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan. shimouchi@jata.or.jp
Tuberculosis (TB) remains a major killer in developing nations, particularly in Asia. Effective control requires nationwide Directly Observed Treatment, Short-course (DOTS) implementation, free anti-TB drugs, and strengthened healthcare to combat rising drug resistance.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: